Notizie economiche
07.02.2024

Company news: Amgen’s (AMGN) quarterly results beat analysts’ forecasts

Amgen (AMGN) reported Q4 FY2023 earnings of $4.71 per share (versus $4.09 per share in Q4 FY2022), beating analysts’ consensus estimate of $4.59 per share.

The company’s quarterly revenues amounted to $8.196 bln (+19.8% y/y), beating analysts’ consensus estimate of $8.126 bln.

The company also issued in-line guidance for FY2024, seeing EPS of $18.90-20.30 versus analysts’ consensus estimate of $19.96 and revenues of $32.4-33.8 bln versus analysts’ consensus estimate of $32.71 bln.

AMGN fell to $315.00 (-0.34%) in pre-market trading.

Guarda anche